Stock Market News

Gene therapy maker bluebird to go private in discounted deal amid cash crunch

Feb 21, 2025 - 15:55
 0
Gene therapy maker bluebird to go private in discounted deal amid cash crunch
Read More

Tags:

Previous Article

Stellantis' $807 million UK lawsuit over airbag, seatbelt cartels dismissed

Next Article

What historical trends tell us about the S&P 500 performance in March

Related Posts

Nissan shares tumble as Foxconn Chair says not seeking a stake

Nissan shares tumble as Foxconn Chair says not seeking ...

Feb 12, 2025  0

Palo Alto raises annual revenue forecast on steady cybersecurity demand

Palo Alto raises annual revenue forecast on steady cybe...

Feb 14, 2025  0

U.S. stocks edge higher; Ukraine, PPI and earnings in focus

U.S. stocks edge higher; Ukraine, PPI and earnings in f...

Feb 13, 2025  0